1086 Modulating the tumor microenvironment via hypoxia activated prodrug CPD100Li induced cell death synergistically enhances anti-CTLA-4 immunotherapy
Main Author: | August Sick |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
From prodrug to pro-prodrug: hypoxia-sensitive antibody–drug conjugates
by: Yanming Wang, et al.
Published: (2022-01-01) -
Targeting Hypoxia: Hypoxia-Activated Prodrugs in Cancer Therapy
by: Yue Li, et al.
Published: (2021-07-01) -
CD80 Expression on Tumor Cells Alters Tumor Microenvironment and Efficacy of Cancer Immunotherapy by CTLA-4 Blockade
by: Julie Vackova, et al.
Published: (2021-04-01) -
Nitroaromatic Hypoxia-Activated Prodrugs for Cancer Therapy
by: William A. Denny
Published: (2022-02-01) -
Improving Cancer Immunotherapy: Exploring and Targeting Metabolism in Hypoxia Microenvironment
by: Jinfen Wei, et al.
Published: (2022-02-01)